Bodhi Tree Biotechnology Inc. (BDTB)

Bodhi Tree Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Assets

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024
Cash & Equivalents	0	0.11	0.26
Cash & Short-Term Investments	0	0.11	0.26
Cash Growth	-96.67%	-57.85%	-
Prepaid Expenses	0.01	0.01	0.01
Total Current Assets	0.02	0.12	0.27
Total Assets	0.02	0.12	0.27

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024
Other Current Liabilities	0	-	0
Total Current Liabilities	0	-	0
Total Liabilities	0	-	0

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024
Common Stock	0	0	0
Additional Paid-In Capital	0.33	0.33	0.33
Retained Earnings	-0.32	-0.21	-0.06
Shareholders' Equity	0.01	0.12	0.27
Total Liabilities & Equity	0.02	0.12	0.27

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024
Net Cash (Debt)	0	0.11	0.26
Net Cash Growth	-96.67%	-57.85%	-
Net Cash Per Share	0.00	0.00	0.02
Filing Date Shares Outstanding	25.44	25.44	25.44
Total Common Shares Outstanding	25.44	25.44	25.44
Working Capital	0.01	0.12	0.27
Book Value Per Share	0.00	0.00	0.01
Tangible Book Value	0.01	0.12	0.27
Tangible Book Value Per Share	0.00	0.00	0.01

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 24, 2026

Data Sources Report a data error